Medigus: ScoutCam Appoints Seasoned Hi-Tech Executive Yovav Sameah as Chief Executive Officer
March 08 2021 - 9:01AM
Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in
advanced medical solutions and innovative internet technologies,
announced today that ScoutCam Inc (OTCQB:SCTC), Medigus’ subsidiary
and a leading developer and manufacturer of customized micro visual
solutions and supplementary technologies, appointed Mr. Yovav
Sameah as ScoutCam’s new Chief Executive Officer. Mr. Sameah will
replace Dr. Yaron Silberman, who will step down to pursue new
opportunities.
Mr. Sameah is a senior level executive with
extensive hands-on experience in management, business leadership
and strategy. He most recently served as CEO of Frontline PCB
Solutions, a non-public worldwide leading provider of
Pre-Production and Industry 4.0 SW solutions in the PCB industry,
presently owned by KLA-Tencor Corp. Prior to Frontline PCB
Solutions, he served as Corporate Vice President and Chief Products
Officer at Orbotech. Earlier in his career, Mr. Sameah held a wide
range of positions from project and product management to senior
managerial positions in the electronic components sector as well as
the PCB hardware and software components industries.
“I would like to first thank Dr. Yaron Silberman
for his significant contribution to ScoutCam over the years. Dr.
Silberman played an essential role in laying the groundwork for
ScoutCam’s transition from an R&D company to an innovative
commercial company,” said Prof. Benad Goldwasser, the Executive
Chairman of the Board of ScoutCam.
Prof. Goldwasser added, “I’m glad to welcome Mr.
Sameah as ScoutCam’s new CEO. Mr. Sameah has vast experience in
leading global hi-tech companies and has a proven ability to
generate significant worldwide sales. ScoutCam is now ripe to
graduate from its status as an R&D phase company, and we will
look to Mr. Sameah to apply his talents and navigate us forward as
we transition to a fully-commercialized international company with
sales and customers across various industries. I am confident that
he will become a significant addition to our management team. This
appointment follows a series of new appointments to ScoutCam’s
leadership as well as to its board of directors. We are excited to
benefit from the expansive network and base of knowledge of our
newly established team and believe their contribution to ScoutCam
will be invaluable.”
About Medigus
Medigus is traded on the Nasdaq Capital Market.
To learn more about the company’s advanced technology, please
visit www.medigus.com.
Cautionary Note Regarding Forward Looking
Statements
This press release may contain statements that
are “Forward-Looking Statements,” which are based upon the current
estimates, assumptions and expectations of Medigus’ management and
its knowledge of the relevant market. Medigus has tried, where
possible, to identify such information and statements by using
words such as “anticipate,” “believe,” “envision,” “estimate,”
“expect,” “intend,” “may,” “plan,” “predict,” “project,” “target,”
“potential,” “will,” “would,” “could,” “should,” “continue,”
“contemplate” and other similar expressions and derivations thereof
in connection with any discussion of future events, trends or
prospects or future operating or financial performance, although
not all forward-looking statements contain these identifying words.
For example, Medigus uses forward looking statements when
describing effective transition of ScoutCam’s outgoing chief
executive officer in place of our new, incoming chief executive
officer, ScoutCam’s ability to maximize the economic potential and
monetize the technology covered in the press release, the material
and positive effect ScoutCam’s incoming chief executive officer
will have on the business and operations, ScoutCam’s ability to
effectively transition from an R&D phase company to a
profitable, commercialized company. These forward-looking
statements represent Medigus’ expectations or beliefs concerning
future events, and it is possible that the results described in
this press release will not be achieved, due to inter alia the
spread of COVID-19 as well as the restriction deriving therefrom
and difficulties arising from the development and manufacture of
wireless charging products. Nothing in the description herein
should be understood or construed as an announcement of completed
products or an existing proof of concept. By their nature,
Forward-Looking Statements involve known and unknown risks,
uncertainties and other factors which may cause future results of
the Medigus’ activity to differ significantly from the content and
implications of such statements. Other risk factors affecting
Medigus are discussed in detail in the Medigus’ filings with the
Securities and Exchange Commission. Forward-Looking Statements are
pertinent only as of the date on which they are made, and Medigus
undertakes no obligation to update or revise any Forward-Looking
Statements, whether as a result of new information, future
developments or otherwise. Neither Medigus nor its shareholders,
officers and employees, shall be liable for any action and the
results of any action taken by any person based on the information
contained herein, including without limitation the purchase or sale
of Medigus’ securities. Nothing in this press release should be
deemed to be medical or other advice of any kind.
Contact (for media only)Oz Adler Chief
Financial Officer +972-8-6466-880 ir@medigus.com
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Apr 2023 to Apr 2024